A Comprehensive Clinical Decision-Making Platform for Robust NGS Analysis

In this presentation at the European Society of Human Genetics (ESHG) conference 2019, Dr. Fabrizio Renzi introduces the Alissa Clinical Bioinformatics Platform from Agilent Technologies that helps to streamline NGS data analysis. In this demonstration, Dr. Renzi presents a whistle-stop tour of Alissa Interpret software, from initiating a new analysis to variant triage and report creation within a fully automatable and customizable workflow.